AKAMIS
Live / Registered — Registered (as of 28 May 2024)
What this means for you
Registered since 28 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97821861
- Registration number
- 7396430
- Mark type
- Stylized text
- Filed
- 03 Mar 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 28 May 2024
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; biotechnological preparations for the medical treatment of solid tumors; biotechnological preparations for the treatment of oncological diseases and disorders
- Class 035 — Advertising and business services: Marketing services in the field of pharmaceutical products; product marketing services in the field of pharmaceutical products; market research in the field of pharmaceutical products; market forecasting in the field of pharmaceutical products; market evaluation services, namely, market analysis and research services in the field of pharmaceutical products; online retail and wholesale store services for pharmaceutical products; online retail and wholesale store services for pharmaceutical preparations; advisory, information and consultancy services relating to the aforementioned services
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development service; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; scientific and medical research in the nature of genome organization and functional analysis; genetic testing for scientific research purposes; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; technological consulting services, namely, product development consultation relating to the manufacture of pharmaceuticals; technological consulting services, namely, product development consultation relating to the design of manufacturing methods for pharmaceuticals; advisory, information and consultancy services relating to the aforementioned services
Owner
- Akamis Bio Limited, Abingdon, Oxfordshire, GB
- Akamis Bio Limited, Abingdon, Oxfordshire, GB
- Akamis Bio Limited, Abingdon, Oxfordshire, GB
Prosecution history
- 11 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2024 — EXAMINER'S AMENDMENT ENTERED
- 29 Jan 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Jan 2024 — EXAMINERS AMENDMENT E-MAILED